Cluster: Health Economy

US expected to impose 100% tariffs on certain drugs: report

US towards imposition of 100% duties on certain drugs

This content was published on Apr 2, 2026 The United States is preparing to impose 100% tariffs on certain drugs of pharma companies that haven't reached an agreement with the White House, the Financial Times reports.

New treatments

Can Swiss pharma giant Roche reshape the obesity market?

This content was published on Apr 2, 2026 Swiss pharmaceutical firm Roche is investing billions in new obesity treatments in hopes of breaking into a highly competitive market.

Nestlé: together with ILO to promote coffee workers' rights

Agribusiness

Nestlé and ILO examine coffee workers’ rights

This content was published on Apr 1, 2026 Nestlé and ILO launch project to improve worker rights and conditions in coffee supply chain .

Easter confectionery rises despite cocoa price slump

Food supply chains

Prices for Easter treats rise in Switzerland despite cocoa price slump

This content was published on Mar 31, 2026 Swiss consumers are not spared from the inflation that has hit Easter cakes.

Is it still worth protecting the identity of Swiss cheese?

In an increasingly globalised food market, how can Switzerland still defend the identity of its cheeses and should it do so?

Join the discussion

Mar 31, 2026

2 Likes

3 Comments

View the discussion

Parmelin ran a family winery before entering government in 2016.

Agribusiness

Switzerland’s wine-making president pushes to restrict imports

This content was published on Mar 30, 2026 Effort to boost local producers draws ire from foreign rivals and domestic merchants.

Agribusiness

The US plans to buy $10 million worth of Swiss cheese – just not from Switzerland

This content was published on Mar 30, 2026 US tariffs are being used to procure Swiss cheese produced by American farmers under a special provision to absorb surplus production and protect rural jobs.

Agribusiness

Former Olympian CEO on hurdles facing Swiss confectioner Kägi

This content was published on Mar 28, 2026 Kägi is navigating a strong Swiss franc, rising raw material prices and sluggish demand in China, its CEO tells Swissinfo in an interview.

A supercomputer is being powered on during a photo op.

AI and medicine

Explainer: why Roche’s supercomputer is a big deal

This content was published on Mar 26, 2026 Pharma companies are racing to acquire microchips and achieve the most powerful AI capacity in the industry. But drug development is tricky and AI talents scarce.

Geneva proposes an alternative to grubbing up vines

Agribusiness

Geneva proposes payment to winegrowers to avoid losing its vineyards

This content was published on Mar 26, 2026 Faced with a major crisis in Swiss winegrowing, the canton of Geneva wants to introduce an alternative to uprooting grape vines.

Cluster: Health Economy

Popular Stories

Most Discussed

Cluster: Health Economy

More

US expected to impose 100% tariffs on certain drugs: report

More

Can Swiss pharma giant Roche reshape the obesity market?

More

Nestlé and ILO examine coffee workers’ rights

More

Prices for Easter treats rise in Switzerland despite cocoa price slump

More

Is it still worth protecting the identity of Swiss cheese?

More

Switzerland’s wine-making president pushes to restrict imports

More

The US plans to buy $10 million worth of Swiss cheese – just not from Switzerland

More

Former Olympian CEO on hurdles facing Swiss confectioner Kägi

More

Explainer: why Roche’s supercomputer is a big deal

More

Geneva proposes payment to winegrowers to avoid losing its vineyards

Popular Stories

Most Discussed